|
US2020361875A1
|
|
Peptide derivatives and therapeutic activity thereof
|
|
EP3160985A1
|
|
Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
|
|
EP3160984A1
|
|
Process for preparing d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
|
|
EP3157907A1
|
|
Process for the preparation of triazolo[4,5-d]pyrimidine cyclopentane compounds
|
|
CN102791696A
|
|
Amino alcohol derivatives and their therapeutic activities
|
|
WO2008001174A1
|
|
Peptide derivatives with therapeutic activity
|
|
WO2008001175A2
|
|
Dipeptide compounds containing d-histidine
|
|
EP1888046A2
|
|
Pharmaceutical formulations comprising active pharmaceutical principles absorbed on titanium dioxide nanoparticles
|
|
EP1761272A1
|
|
Compositions containing d-carnosine
|
|
US5973199A
|
|
Hydrosoluble organic salts of creatine
|
|
ITMI942092D0
|
|
Process for amination through coupling with the use of non-toxic aromatic amines
|
|
ITMI931600A1
|
|
Salts of 5-nitro-2-phenoxymethane sulphanilide with L- lysine and L-ornithine and their pharmaceutical use
|
|
IT8402909D0
|
|
Pharmaceutical O-acetyl-1-carnitine chloride prepn.
|
